Elite Pharmaceuticals, Inc. (ELTP)
Manufactures generic and branded oral medications for pain, weight loss, and nervous system disorders.
$0.38-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-23.5%
The outlook
ELTP is trading near the lower end of its 52-week range and mixed relative to its moving averages. Analyst sentiment leans bearish overall. The stock carries a trailing P/E of 12.5, though thin or absent analyst coverage may limit visibility into consensus price targets.
What’s behind the score
Price trendMixed vs its moving averages
52-week range11% of the way from its 52-week low to high
Market cap
$403.9M
52-wk high
$0.74
52-wk low
$0.33
50-day avg
$0.37
200-day avg
$0.44
Trailing P/E
12.5